TrueBlue (TBI) EBITDA (2009 - 2026)

TrueBlue (TBI) has 18 years of EBITDA data on file, last reported at -$19.8 million in Q1 2026.

• Quarterly EBITDA fell 37.96% year-over-year to -$19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.9 million (up 62.19% YoY) and the FY2025 annual result came in at -$47.4 million, up 62.73% from the prior year.
• EBITDA improved to -$19.8 million in Q1 2026 per TBI's latest filing, from -$31.4 million in the prior quarter.
• Across five years, EBITDA topped out at $22.3 million in Q2 2022 and bottomed at -$104.5 million in Q2 2024.
• The 5-year median for EBITDA is -$2.2 million (2023), against an average of -$8.9 million.
• The widest annual swing landed in 2024, when EBITDA slumped 1432.77%; it then jumped 100.45% in 2025.
• Tracing TBI's EBITDA over 5 years: stood at $7.4 million in 2022, then sank by 129.54% to -$2.2 million in 2023, then slumped by 528.64% to -$13.8 million in 2024, then tumbled by 127.59% to -$31.4 million in 2025, then surged by 36.79% to -$19.8 million in 2026.
• Per Business Quant, the three latest TBI EBITDA figures stand at -$19.8 million (Q1 2026), -$31.4 million (Q4 2025), and -$2.1 million (Q3 2025).

Peer Comparison